Uveitis, Anterior
Inflammation of the anterior uvea comprising the iris, angle structures, and the ciliary body. Manifestations of this disorder include ciliary injection, exudation into the anterior chamber, iris changes, and adhesions between the iris and lens (posterior synechiae). Intraocular pressure may be increased or reduced.
Subtype terms (3)
More specific conditions that are subtypes of Uveitis, Anterior in the MeSH hierarchy.
- Behcet Syndrome
49 drugs (38 approved, 11 experimental)
- Iridocyclitis
4 drugs approved
- Iritis
5 drugs approved
Drugs by status
Approved for this indication (3)
Phase 4 trials (10)
Phase 3 trials (10)
Phase 2 trials (6)
Phase 1 trials (1)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (9)
Organization Involved with Phase 3 Indications (14)
- Alcon
- Aldeyra Therapeutics, Inc.
- Allergan
- Clearside Biomedical, Inc.
- Eyegate Pharmaceuticals, Inc.
- Lux Biosciences, Inc.
- Chulalongkorn University
- University of California, San Francisco
- Virginia Eye Consultants
- National Taiwan University
- KhonKaen University
- Hokkaido University
- Assistance Publique - Hôpitaux de Paris
- Hwang Pacific Foundation
Organization Involved with Phase 2 Indications (9)
Organization Involved with Other Experimental Indications (2)